The researchers say that research thus far has focused on developing treatments to manage idiopathic epilepsy and little attention has been given to the emotional and logistical challenges for owners managing their dog’s condition.
This study used semi-structured interviews to explore how owners’ lives were changed following their dogs’ diagnosis and glean in-depth insights into their lives.
The research discovered that following their dog’s initial seizure, all interviewees recalled feeling negative emotions such as being distraught, fearful or uncertain regarding their dog’s future and disease progression. Prior experience with canine epilepsy was rare, and owners were shocked and distressed by the appearance of their dog’s seizures.
Whilst many owners discussed a very emotionally close dog-owner bond, owning a dog with epilepsy had a significant impact on their lifestyle. Impacts affected many aspects of daily routines, and in some cases, owners’ jobs. The unpredictable and sometimes inconvenient timing of seizures negatively impacted owners’ sleep and wellbeing. This unpredictability also made some owners feel that they were living with “a ticking time bomb”.
Other limitations included strict daily medication schedules and difficulty finding assistance in caring for their dog. This, combined with a fear of leaving their dog unsupervised, had social implications in some instances and led to increased use of the Internet and online groups for peer support. Owners also reported that friends, family and colleagues did not always understand the magnitude of commitment required.
Amy Pergande, Small Animal Intern at the RVC and primary author of the study, said: "We are sincerely grateful to the owners who participated in this study for providing us with such detailed and often emotive accounts of their experiences. Many of the participants had willingly altered many aspects of their daily routine for their dogs, both socially and professionally, and sometimes at the expense of their own quality of life."
This research highlights that further consideration of these factors by veterinary professionals and the friends and families of owners of these dogs could improve owner quality of life and facilitate the provision of additional, much needed support.
Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science and research lead in canine epilepsy at the RVC, said: "Epilepsy can be an extremely tough condition for owners to manage, where the love, time and money owners dedicate to their dogs is not necessarily matched by a significant improvement in their condition, with seizures often continuing unabated. Our study has revealed previously unrecognised or under-appreciated impacts that epilepsy introduced to these owners’ lives. Improved awareness and understanding of these challenges by veterinary professionals have the potential to improve communication with clients, to avoid owners feeling that social media is the only place they can go to feel supported and understood”.
These findings increase the understanding of the sometimes negative and often profound emotional effects and lifestyle changes experienced by owners managing a dog with idiopathic epilepsy. With better support and resources, the reported impacts could potentially be minimised to protect owner quality of life.
Zoe Belshaw, independent research collaborator, said: “The welfare of pets and their owners can be closely intertwined. This research exploring how owners’ lives change when their dogs develop epilepsy is another important piece in the jigsaw of understanding both what the veterinary profession can do to best support our clients, but also in starting to appreciate the substantial wider societal impacts of chronic ill health in our nations’ pets”.
The full paper is open access and available at: https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-020-02669-w
Reference
Photo: The Melias Studio
The Essity Veterinary Academy covers four topics of education: Anatomy and Physiology of Wound Healing, Infection Management, Exudate Management and a Wound Assessment Workshop.
Richard Barker, Account Sales Executive said: "Essity Veterinary Academy events allow us to educate veterinary professionals with a full, comprehensive day of wound management.
"We have run our Academy events for the last two years and the feedback we have had has always been positive, therefore the decision to run four events again this year was an easy one.
"The events offer a great opportunity to share best practice with other veterinary professionals, and to obtain invaluable information from our Medical Education Manager, who has vast experience in dealing with all areas of wound management. We are very lucky to be able to offer these events free of charge and we can’t wait for the first event to begin on 18th June."
Essity is hosting these events across four venues, with the days running from 09:00 – 16:00, refreshments and lunch provided. The venues available this year are:
18th June, Huntingdon Racecourse
9th July, West Midlands Safari Park
17th September, Durham Cricket Club (Emirates Stadium)
24th September, Edinburgh Zoo
To book your place, email animalhealthcare@essity.com, giving your name, job title, practice details, telephone number and any dietary requirements.
Alternatively, if you would like further information please dial 01482 670124.
The expansion has increased the hospital's footprint by 30%, adding three new operating theatres, six new consult rooms and new feline facilities, including a cat-only waiting room, consult room and treatment area.
Hospital owner, IVC Evidensia said the expansion has been driven in part by the pet ownership boom of the last few years and increased demand for the hospital’s services.
To meet the demand, Vale has expanded its office space, adding desk space for a further 25 vets.
There are also new ultrasound and cardiology rooms, a new dental suite and enlarged prep and recovery areas.
The existing kennel area has doubled in size with the addition of nine new walk-in kennels, a bespoke isolation ward and secure outdoor runs.
Richard Artingstall, clinical director at Vale Referrals, said: “We’ve been working on this expansion for a long time and it’s incredible to see it complete.
"Our new and improved facilities mean we can give even more pets across the Southwest the gold standard treatment that they deserve and support our colleagues from neighbouring vet practices with extensive referral services.
"The feedback from pets and owners so far has been very rewarding to hear.”
The feedback from pets?
Really?
VetSurgeon.org contacted recent patient Dougal McDoggins for comment.
He said: "Woof."
www.valereferrals.co.uk.
PhotonUVC Vet is a non-contact treatment which emits low dose ultraviolet C light at a targeted area.
Photon Therapeutics says the device kills bacteria, viruses, fungi and other infecting organisms while being safe to host tissues.
Other claimed benefits of the device are that it avoids client compliance issues associated with eye-drops, it eliminates the need for antibiotic eye drops, and it is very simple to learn how to use.
The device costs £4,995.
To explain more about The PhotonUVC Vet, Dr. Simon Dean. MBChB, MSc, FRANZCO, FBCLA Chief Scientific Officer at Photon Therapeutics, and Dr. Mark Leddy BVSc, MBA, CEO, will be delivering a CPD presentation at the Exhibitor Showcase Theatre 3: "5 Amazing Seconds – A New Transformative Treatment for Corneal Infections", on Thursday 14th November at 3pm.
There is also a launch event reception at the stand from 16.15 to 18.15 on Thursday 14 November.
https://photon-therapeutics.com/
Carl's article: 'Are you using a safety checklist in your practice?', focuses on the benefits of introducing a safety checklist in practice to reduce patient morbidity, mortality and to improve communication between members of the veterinary team.
He explains how a checklist helps eliminate the need to memorise every single step of a protocol and self-limit any errors that may eventually lead to a fatal or near-fatal incident, and how it should contain a limited number of elements, allow quick completion and most importantly be relevant to the situation.
The article includes information on how to introduce a safety checklist, steps to consider and how to use one in practice.
It also contains links to downloadable tools including the Association of Veterinary Anaesthetists (AVA) safety checklist and implementation booklet and information on the association’s ‘Safer Anaesthesia Project’. An editable safety checklist will also be available to download from the ‘Anaesthesia1ST’ blog that practices can adapt to their own requirements.
Richard Beckwith, country manager of Jurox (UK) said: "Our hugely popular Anaesthesia1ST newsletter features state-of-the-art, practical and easy to read articles to help veterinary professionals deliver 1ST class anaesthesia to all patients. Our latest edition will challenge practices to consider safety checklists as an essential part of their pre-anaesthetic routine in order to reduce the risk of mistakes."
To sign up to the Anaesthesia1ST newsletter visit the Alfaxan website – www.alfaxan.co.uk, contact your local Jurox technical sales representative or email Jurox at info@jurox.co.uk.
The group attributes part of its success to the various initiatives it runs for employees, including a scheme through which every member of its 220-strong team is allowed five fully paid donation days each year so they can volunteer to support meaningful local causes.
Employees also receive a £500 cash gift when they become new parents or adopt a child and can take 'peternity leave', which offers anyone with a new pet two fully paid days off work to help the animal settle into their new home.
Team members also get birthdays off (with cakes), a health care scheme, subsidised Fitbits and gym memberships.
Tim Harrison, managing director at White Cross Vets, said: "Making White Cross Vets a great place to work is vitally important to us, especially because our people are such a fundamental part of our success. Plus we’ve just launched the second of five new practices that will open during a 12-month period, so we’re continually expanding and recruiting.
"Being at the forefront of the veterinary industry with a wide range of innovative and high-quality employment initiatives, many of which are ideas from individual team members, helps us to attract and retain the best people. This enables us to grow quickly whilst fostering a close-knit and highly motivated team. This ethos also translates into the level of care and standard of service that our clients receive, which is something we’re very proud of."
The Royal College of Veterinary Surgeons is warning veterinary surgeons to be on their guard after it came to light that a fraudster is charging a £150 'non-refundable application fee' for an RCVS 'internship' which does not exist. Apart from anything else, the RCVS does not offer internships.
Information about the fake internship has been sent to individuals registered with German website http://www.vetcontact.com/. It includes details about the Royal Veterinary College and the RCVS, but is basically fiction. It refers to a made up 'RCVS Hospital' in the 'Flint Hills of London'.
Gordon Hockey, RCVS Head of Professional Conduct said: "So far, only a handful of veterinary surgeons - all based overseas - have contacted us regarding the internship and queried the request for a non-refundable 'application' fee, although we are concerned that others may have been caught out.
"We would advise any veterinary surgeon to think twice before paying for a third party to facilitate an application for any placement or internship, and reiterate that the RCVS does not offer any such programmes."
The College is following up the situation with http://www.vetcontact.com/ and, if appropriate, will notify the police. In the meantime, anyone who is concerned that they may have fallen victim to the hoax should contact the RCVS Professional Conduct department on 020 7202 0728.
Vet Futures, the joint initiative by the RCVS and BVA to stimulate debate about the future of the profession, has opened a new discussion hospice care, and whether it it will become mainstream in veterinary medicine.
This month's Vet Futures guest blogger, Kath Dyson, a former veterinary surgeon who qualified from Glasgow in 1989, writes that veterinary palliative care, while a relatively recent phenomenon, has been growing in stature, particularly in the United States, with symposia and conferences on the subject as well as webinars and chapters in text books.
She notes the increasing number of UK vets offering hospice care, highlighting the differences between palliative services offered in human and veterinary medicine as well as debates within the profession over the advantages and disadvantages of palliative care versus euthanasia.
She said: "In animal hospice it is the pet's owner who takes on all the financial, practical and emotional costs involved, whereas human patients have a lot more support available. Euthanasia is always an option in veterinary medicine, and indeed euthanasia of an animal can legally be carried out by anyone, so long as it is done humanely."
On the euthanasia debate she adds: "Some regard euthanasia as more of a last resort, with hospice assisted natural death being seen as more preferable and only a minority of patients requiring euthanasia. Others feel that euthanasia is more often likely to be the preferable outcome of a period of hospice care in the animal patient, even though they do not rule out a natural death."
Overall she argues that additional expertise from veterinary surgeons in end of life care will help the profession be "even better able to provide truly lifelong care to all their animal patients".
To accompany Kath Dyson's article, this month's poll asks if hospice care will become a standard part of practice.
Last month's poll asked if vets are given adequate information, guidance and support on ethnic and cultural diversity in relation to a blog written by a British Asian vet about prejudice he encountered from a client. The vast majority (90%) of the 118 people who responded to the poll thought that the profession was lacking in support when it came to diversity. Diversity in the profession and how to increase it has been a key topic identified by the project and it will be one of the issues addressed in the final Vet Futures Report published later this year.
To take part in this month's poll and to read and comment on Kathy Dyson's blog visit www.vetfutures.org.uk/discuss
Virbac has launched Propofol-Lipuro Vet, a short-acting intravenously administered and short-term maintenance general anaesthetic for use in dogs and cats.
Propofol-Lipuro Vet contains no preservatives so its use can be repeated, even in cats, for continuous rate infusion. No age restrictions apply to the animals it can be used for and it can be administered for induction prior to Caesarean section.
Virbac Product Manager Kate Woolley MRCVS said: "Propofol is a well-established solution for short-acting anaesthesia in many practices. Propofol-Lipuro Vet complements Virbac's anaesthesia range which now offers total control of analgesia, sedation, intravenous and gaseous anaesthesia, and recovery."
Propofol-Lipuro Vet is available in boxes of 10 x 20 ml bottles.
The charity points out that with the arrival of winter, so comes an increase in the number of cats poisoned by antifreeze. For this reason, it has produced the poster to try and raise awareness of the fact that due to their specialised metabolism, a teaspoon or less of antifreeze can be enough to cause serious illness or death and even a curious lick of a small spillage can be enough to poison a cat.
The poster can be downloaded free of charge here: https://icatcare.org/sites/default/files/PDF/antifreeze-campaign-poster.pdf.
Alternatively, a hard copy can be ordered from the iCatCare shop for a small fee to cover postage: https://icatcare.org/product/antifreeze-poster
More information for pet owners can be found at: https://icatcare.org/advice/keeping-cats-safe/antifreeze
Centaur has launched a new service on the MyCentaur website which allows for 24-hour ordering from any broadband enabled computer.
A secure practice shopping list with controlled staff access to ordering and management information enables practices to safely control any buying.
According to the company, a key feature of the website is that any orders placed on line by 9pm will be delivered the following day, which gives practices even greater flexibility on ordering times over any existing vet wholesaling ordering service. As well as greater convenience, a financial benefit in using this method of ordering is that all on-line orders attract an additional two per cent discount.
The award was due to be presented at the association's annual shindig in March, which was cancelled due to the coronavirus pandemic.
VMA Awards chair, Claire Edmunds, said: “This years’ winners will still get their moment of glory on stage next March at the rescheduled event. We can also announce that the event is likely to include some additional categories to recognise campaigns and initiatives undertaken during the COVID-19 pandemic.”
Carlos Michelsen, managing director of award sponsor, CM Research, added: "Thanks to the continued success of Cytopoint, Zoetis achieved highly commended status. But it was Elanco that came in as award winners, with their novel veterinary pharmaceutical product Galliprant taking the crown. Congratulations to Elanco!"
Rebecca Bryant, Elanco’s marketing manager for Pet Health Therapeutics (pictured right), said “Elanco is delighted to be recognised by the veterinary community with this prestigious award for Galliprant. The UK team is proud to be part of the launch of this innovative, first-in-class product which has already enriched the lives of thousands of pet owners and their dogs living with osteoarthritis. It’s fantastic to hear from vets that managing OA with Galliprant has already made a positive impact on their practices.”
Zoetis product manager, Allison Henry said: “We are very proud to come such close second in this award category as it is a true testament to the lasting innovation Cytopoint has brought to our industry, customers and pets. At Zoetis, we always strive to develop innovative new medicines for the veterinary industry and we are thrilled to see how Cytopoint has done just that.”
The charity, which helps around 200,000 cats and kittens in the UK each year needs someone with animal welfare skills to join its team of nine trustees who are responsible for the charity’s strategy, policy and oversight.
The ideal candidate will have a degree in veterinary medicine, animal behaviour or an equivalent qualification, together with an understanding of the voluntary sector and management experience gained at a large national organisation, university or veterinary practice.
Sue Field, Cats Protection’s Director of Volunteering, said: "This is an exciting role which focuses on further improving cat welfare, whether that be cats in Cats Protection’s care or the services that we offer to cat owners to help them better care for their pet.
"We deliver our work through over 10,000 volunteers and staff so we’re hoping to attract a strong team player who would enjoy the challenge of shaping strategy and policy across our large and multi-faceted organisation.
"In return we can offer the opportunity to develop new and existing skills at trustee level plus the opportunity to make a real difference to the welfare of cats and kittens. If this sounds like a challenge you’d relish, then we’d love to hear from you."
To apply for the role, visit https://www.cats.org.uk/get-involved/volunteering/find-an-opportunity?id=3954.
If you would like an informal chat about the role, contact Clare Radlett on 01825 741211 or email: claire.radlett@cats.org.uk
The closing date for applications is 5pm on Monday 19th February 2018.
California-based Signostics, Inc. has launched SpeqViewTM, billed as the world's smallest and most cost-effective veterinary ultrasound device.
Using MotionScape and SectorView technology, and offering multiple transducer frequencies, the SpeqView delivers high-resolution images for key veterinary applications including: cystocentesis; bladder volume; foreign object localization; abdominal imaging; and musculo-skeletal diagnosis.
Jeff Green, Signostics Vice-President of Sales and Marketing said: "The SpeqView provides a break-through for veterinary practices. For the first time there is an ultrasound device that is highly portable, simple to use and individually affordable. The SpeqView improves veterinary practice efficiency and income by allowing immediate diagnosis in the consulting room, or in the field and by providing better animal care.
He added: "Weighing a little over half a pound, the SpeqView features extended battery life and amazing portability, and is worn around your neck like a stethoscope or placed in your pocket until the next use."
The SpeqView is configured to use 3.5MHz and 7.5MHz transducers and comes with a comprehensive warranty, which covers the system and transducers and eliminates the need for annual service contracts. Signostics also offers extensive training and education programs delivered on site, online and in collaboration with leading veterinary institutions and educators. No interest, twelve-month financing is available.
For more information visit www.SpeqView.com or contact Signostics on 001 877 5744667.
The Blue Cross is calling for nominations from veterinary practices across the country for its Veterinary Nurse of the Year Award 2010.
The annual award is presented at the British Veterinary Nursing Association (BVNA) Annual Congress in October. It recognises the contribution of veterinary nurses in educating the public about responsible pet ownership and the welfare of pets in the community.
Last year's award was won by Vania Brasseleur for her outstanding contribution to animal welfare, both within her veterinary practice and among the local community in Newport Pagnell, Buckinghamshire
Vania was nominated for the award by student vet nurse and colleague Emily Martin at Astonlee Veterinary Hospital in Newport Pagnell.
Emily said: "Vania is committed to helping student nurses broaden their knowledge and help them on to the path to qualification. Her charity work, serving the public, helping colleagues and of course her nursing abilities are all truly fantastic! I don't think anybody could ask for a better nurse."
Nominations for this year's award can be made by completing the nomination form on The Blue Cross website at: www.bluecross.org.uk/BVNA2010 or by contacting Sally Leathem on 01993 825577. The deadline for nominations is Friday 20 August 2010.
'FLUTD and Dysuria – a frustration for many and not just the cat' will be presented by Dr Hanne Friis Lund (DVM) from Idexx and Katy Smith from Royal Canin (pictured right).
Hanne will be talking about diagnostics, focusing on urine analysis and laboratory tests, whilst Katy will discuss nutritional management of the condition.
Hanne said: "Feline lower urinary tract disease is a very common condition in both male and female cats affecting 1-3% of cats every year.
"It goes without saying that FLUTD causes great discomfort and pain for the feline, which is why the webinar will explore how best to manage the condition from a nutritional point of view.
"From the innovative Haematuria Detection by Blücare litter granules which turn blue when a urinary condition is detected to the new urinary range kibble from Royal Canin’s Veterinary Health Nutrition, the webinar will be leaving no stone unturned."
To register for the webinar, go to: https://vetportal.royalcanin.co.uk/cpd/webinar/
Ceva Animal Health has announced the launch of Vectra Felis, a new spot-on flea treatment for cats.
The new product contains two active ingredients: dinotefuran and pyriproxyfen. The first is an adulticide which Ceva says kills fleas on contact, thereby stopping fleas biting before they die. The second ingredient is an Insect Growth Regulator (IGR) which prevents flea reproduction and adult flea emergence, so protecting the cat and its environment from future flea attacks.
According to the company, Vectra Felis ensures that over 95% of fleas are killed within two hours and the effects last for a month.
In addition, Ceva highlights the product's patented applicator, which has an elongated smooth tip for quick and easy application. The company says it also provides accurate dosing and facilitates clean administration as nothing comes out until the tube is squeezed. Kittens can be treated from seven weeks of age (weighing at least 0.6kg).
For further information on Vectra Felis, contact your local Ceva territory manager or call 01494 781510.
Micro-nutrition specialist Agrimin has launched All-Trace Biotin Gold, the seventh bolus in the company's All-Trace range.
The new bolus is the result of extensive in-house research and development which aimed to formulate a cost-effective, micro-nutrition bolus suitable for dry cows and heifers at risk from lameness, which affects up to 20 per cent of the UK national herd. According to Agrimin, the relationship between Biotin and its benefits on ruminant hoof health is receiving increasing attention. The company says it is the first micro-nutrition specialist to directly address this livestock health issue by using a bolus.
The Biotin Gold bolus for dairy cows and heifers delivers the target level of 20 mg per head, per day of Biotin over 120 days. In addition, the bolus also delivers the full, daily requirement of copper, cobalt, selenium and iodine as well as levels of zinc, manganese and vitamins A, D3 and E.
Administration is simple and convenient during the drying off period as many livestock are already going through a crush to have their feet trimmed and undergo other healthcare routines such as intramammary treatments.
For dry cows, two boluses are given to each cow at the point of drying off. They lie in the rumen/reticulum and slowly dissolve from a constant surface area providing a continuous and regular supply of trace elements and vitamins to the animal. The boluses dissolve completely and leave no residue in the rumen.
Agrimin says heifers respond very well to Biotin supplementation and studies have shown that supplying Biotin in the later stages of pregnancy produces the most effective results. This late stage of pregnancy is also the critical period for the transfer of vital nutrients from mother to calf and so the trace element content of All-Trace Biotin Gold will benefit both animals. Two boluses are given to each heifer at around three months pre-calving.
All-Trace Biotin Gold is available in packs of 20 boluses, which will supplement 10 cows or heifers at a cost of around £9.50 per animal for two boluses. For more information about bolus technologies and micro-nutrition, please visit www.agrimin.com or call 01652 688046.
This, says the company, suggests that infection could be more common among seemingly healthy dogs than vets or owners realise, which may mean there is a greater risk of perioperative bleeding caused by the coagulopathies associated with A. vasorum2 than previously thought.
Elanco says another recent study indicates that there may be a bigger environmental risk for dogs than previously thought, too.
In the study, by Robbins et al, L3 larvae of A. vasorum and Crenosoma vulpis arising from the gastropod intermediate host were found to be immediately infective to dogs and remain so for up to eight weeks, meaning that dogs may only need to lick the molluscs’ slime to be at risk of infection.3
Elanco says this new data means A.vasorum should be added to many differential diagnosis lists, and that pre-operative testing could also be wise.
Jenny Helm, BVMS Cert SAM Dip-ECVIM CA FHEA MRCVS, European Specialist in Small Animal Internal Medicine, said: “Owners need to be aware that healthy dogs could be silently carrying and spreading the disease and that asymptomatic carriers could develop clinical signs at any time.
"They need to be aware that dogs don’t necessarily have to eat slugs and snails to become infected, as recent evidence suggest that other routes of transmission are possible.” To improve data on the prevalence of lungworm, Elanco has developed a version of its lungworm map specifically for veterinary surgeons, where you are invited to upload your cases (including asymptomatic positive cases: www.lungwormmap-vet.co.uk.
For those practices which want to run lungworm awareness campaigns in their area, Elanco has a how-to guide, posters and artwork available to download at www.myelanco.co.uk.
References
The Disciplinary Committee of the Royal College of Veterinary Surgeons has dismissed a case against a Staffordshire veterinary surgeon, having found that his convictions under the Criminal Justice Act 1988 and the Public Order Act 1986 did not make him unfit to practise veterinary surgery.
At the one-day hearing, the Committee heard that Mr Richard Conlon of Warrendale Veterinary Care Centre, Biddulph, was convicted of one instance of common assault and one public order offence involving threatening, insulting or abusive language, both of which occurred during an altercation in a public house in Biddulph on 28 November 2009. The court ordered Mr Conlon to pay two fines of £300 each, a victim surcharge of £15, and £700 of court costs.
As the facts involved in Mr Conlon's offences had been proved by the court that convicted him, and Mr Conlon admitted to his convictions, the Committee considered only whether these offences made him unfit to practise veterinary surgery.
The Committee was advised that although the convictions were unrelated to Mr Conlon's professional practice, any criminal conviction may call into question a veterinary surgeon's fitness to practise if the conduct for which they are convicted raises doubts over their capability as a veterinary surgeon. Convictions that damage the wider public interest in the good reputation of the profession and public confidence can also raise questions about fitness to practise and may be considered.
Speaking on behalf of the Disciplinary Committee, Vice-Chairman Professor Sheila Crispin said: "In reaching our decision, it is important to emphasise that the Disciplinary Committee does not condone Mr Conlon's behaviour in any way. We accept the submission of the College 'that it is incumbent on any veterinary surgeon to act with decorum and not to engage in any violent, aggressive or intimidating behaviour,' and, on any view, for a veterinary surgeon to get involved in a brawl in a public house is unacceptable behaviour.
"In the Committee's judgment this was a one-off incident of brief duration with no premeditation on Mr Conlon's part; fortunately no significant injury was suffered by anybody involved. From the nature of the charges and the sentence of the court, it can be seen that this was at very much the lower end of seriousness and, as is accepted by the College, involves no concern about Mr Conlon's ability to practise as a veterinary surgeon."
The Committee ordered the charges be dismissed.
The improvements include a new cat ward designed to offer a quieter, more relaxing area away from other animals, and a new walk-in dog ward which will allow staff to treat larger breeds of dogs more easily. The intensive care unit has been expanded and the practice has developed a new chemotherapy area.
John Turkington, the partner at Scarsdale Vets responsible for overseeing the work said: "We are already really proud of the state-of-the-art facilities we have at Pride, but we are not complacent and that is why we have made this significant investment to improve our facilities and ultimately the services we offer our clients and patients. Patient comfort is paramount, which is why we’ve invested in an additional walk in ward for our larger breeds, and a new cat ward with a separate feline examination and treatment area."
As well as the changes to improve clinical care, the practice has also invested in its kennelling services, increasing the number of 'suites' for cats and dogs to stay in its 'hotel' areas whilst their owners go on holiday.
John added: "We want Pride to be recognised as one of the best veterinary hospitals in Europe and to make that a reality we have increased our ward capacity for patient comfort and clinical treatment areas, as well as improving facilities behind the scenes for our staff, to create a better working environment. Alongside that the improvements to our Pet Resort will also meet the growing demands from clients for those services."
The company says Cevaprost can help improve breeding success in reproduction protocols in cattle and has the following indications:
Ceva says these indications are equivalent to those of the leading racemic and single isomer cloprostenols available in the UK.
Cevaprost is available in a 20ml colourless glass vial and in a multi-pack of 10 x 20ml vials. It can be administered in single or repeated 2ml doses (equivalent to 0.5mg of cloprostenol) by intramuscular injection. It has a withdrawal period of one day for meat and no withdrawal period for milk.
Peter Keyte, ruminant business unit manager at Ceva Animal Health, said: “We are delighted to add Cevaprost to our extensive range of reprodAction products to provide vet and farmers with comprehensive cattle reproduction solutions and improve breeding success in reproduction protocols.”
For further information, contact your local Ceva territory manager or email cevauk@ceva.com.
Miss Panait faced the charge that on 3 April 2018, at Cardiff Magistrates’ Court, she was convicted of causing serious injury by dangerous driving for which she was sentenced to 10 months in prison, disqualified from driving for 41 months and ordered to pay a victim surcharge of £140.
At the start of the hearing Miss Panait admitted to the charge against her which related to an accident on 15 May 2017 in which, following an attempt to overtake a number of vehicles, she lost control of her car and collided with a vehicle on the other side of the road, causing serious injuries to herself and life-changing injuries to the other driver. The Committee subsequently found this charge to be proved.
The Committee then considered whether the charge found proved made her unfit to practise veterinary surgery.
In doing so, it took into account the fact that Miss Panait was convicted of a serious crime which resulted in serious harm to another and for which she received a custodial sentence.
The Committee decided that the criminal conviction and the custodial sentence fell far below the standard expected of a veterinary surgeon and therefore rendered her unfit to practise veterinary surgery.
In considering her sanction, the Committee heard directly from Miss Panait who attended the hearing having been released from prison on licence.
Stuart Drummond, chairing the Committee and speaking on its behalf, said: "After the submissions the respondent spoke directly to the Committee. She was understandably emotional and was remorseful and apologetic. She acknowledged that she had made a mistake and apologised for bringing the profession into disrepute…. To the Committee her sense of personal responsibility or shame was palpable."
The Committee also took into account other aggravating and mitigating factors in the case.
The Committee recognised that it was a serious offence with significant consequences for both the victim and Miss Panait but accepted it was a single isolated incident, that Miss Panait has made efforts to avoid repetition of the incident by undertaking further driving instruction and recognised that she had displayed full insight and remorse. Furthermore, it also considered the many testimonials from colleagues and clients and that she had received significant support from her employers.
Mr Drummond added: "The Committee came to the conclusion that this was one of those exceptionally unfortunate and sad cases where it is appropriate and proportionate to take no further action. The respondent has insight and is deeply remorseful and has accepted full responsibility for what has happened.
"In the circumstances of this case the Committee determined that the public interest has been met by the finding that the respondent’s conviction renders her unfit to practise. The Committee was of the view that to impose any sanction now would be disproportionate."